| |
| |
|
| Insider
Information: |
Klein Joseph III |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
86,717 |
|
|
Indirect Shares
|
111 |
|
|
| Direct
Value |
$3,808,463 |
|
|
|
Indirect Value
|
$4,092 |
|
|
| Total
Shares |
86,828 |
|
|
| Total
Value |
$3,812,555 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
3
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
-3.0
|
| Percentage
Gain/Loss : |
 127.5%
|
 -73.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
NPS Pharmaceuticals Inc |
NPSP |
as of May 22, 2007 |
2007-05-23 |
0 |
2003-09-11 |
0 |
Premium* |
|
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2010-03-08 |
35,000 |
2007-03-07 |
0 |
Premium* |
|
|
Clinical Data Inc |
CLDA |
Former Director |
2006-10-11 |
1,000 |
|
0 |
Premium* |
|
|
Ionis Pharmaceuticals Inc |
IONS |
Director |
2024-05-03 |
16,346 |
2024-05-03 |
100 |
Premium* |
|
|
Savient Pharmaceuticals Inc |
SVNTQ |
Director |
2010-06-08 |
17,388 |
2006-06-01 |
0 |
Premium* |
|
|
PDL Biopharma Inc |
PDLI |
Director |
2009-11-04 |
16,983 |
2009-11-04 |
11 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
178 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2008-06-02 |
4 |
S |
$26.47 |
$105,880 |
D/D |
(4,000) |
6,426 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
Director |
– • – |
2003-10-01 |
4 |
AS |
$27.01 |
$54,023 |
D/D |
(2,000) |
0 |
|
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2013-08-09 |
4 |
S |
$28.22 |
$529,126 |
D/D |
(18,750) |
8,313 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2017-11-15 |
4 |
OE |
$28.47 |
$64,058 |
D/D |
2,250 |
9,377 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2017-11-30 |
4 |
OE |
$28.47 |
$85,410 |
D/D |
3,000 |
12,939 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2017-12-15 |
4 |
OE |
$28.47 |
$85,410 |
D/D |
3,000 |
12,939 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2017-12-29 |
4 |
OE |
$28.47 |
$85,410 |
D/D |
3,000 |
12,939 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
Director |
– • – |
2004-04-01 |
4 |
AS |
$28.69 |
$28,694 |
D/D |
(1,000) |
3,100 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
Director |
– • – |
2003-09-23 |
4 |
AS |
$29.84 |
$59,688 |
D/D |
(2,000) |
0 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
Director |
– • – |
2004-03-03 |
4 |
AS |
$29.88 |
$59,753 |
D/D |
(2,000) |
3,100 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
Director |
– • – |
2004-01-02 |
4 |
OE |
$31.15 |
$62,301 |
D/D |
2,000 |
0 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
Director |
– • – |
2003-12-02 |
4 |
AS |
$31.20 |
$62,409 |
D/D |
(2,000) |
0 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
Director |
– • – |
2003-09-11 |
4 |
S |
$31.50 |
$85,050 |
D/D |
(2,700) |
0 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
Director |
– • – |
2004-01-06 |
4 |
A |
$31.60 |
$97,960 |
D/D |
3,100 |
3,100 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
Director |
– • – |
2004-02-02 |
4 |
AS |
$33.95 |
$67,907 |
D/D |
(2,000) |
3,100 |
|
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2021-07-15 |
4 |
AS |
$35.30 |
$152,989 |
D/D |
(4,334) |
18,126 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2018-01-16 |
4 |
OE |
$35.53 |
$106,590 |
D/D |
3,000 |
11,339 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2018-01-30 |
4/A |
OE |
$35.53 |
$106,590 |
D/D |
3,000 |
12,939 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2018-02-15 |
4 |
OE |
$35.53 |
$106,590 |
D/D |
3,000 |
11,539 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2018-02-28 |
4 |
OE |
$35.53 |
$106,590 |
D/D |
3,000 |
12,039 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2019-12-02 |
4 |
OE |
$35.53 |
$35,530 |
D/D |
1,000 |
13,683 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2019-12-09 |
4 |
OE |
$35.53 |
$35,530 |
D/D |
1,000 |
13,683 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2019-12-16 |
4 |
OE |
$35.53 |
$35,530 |
D/D |
1,000 |
13,683 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2019-12-23 |
4 |
OE |
$35.53 |
$35,530 |
D/D |
1,000 |
13,683 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2013-11-25 |
4 |
S |
$36.86 |
$221,156 |
D/D |
(6,000) |
2,313 |
0 |
- |
|
178 Records found
|
|
Page 6 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
